Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Scars: early-phase trial registry
2 of 5 indexed Scars trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Scars: 5 US clinical trials tracked, 2 recruiting.
Scars is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is AVAVA, running 2 of these trials.
Enrollment posture brief
Registry condition scars
OPEN 2 | RECR 40% | LATE 0 | EARLY 1 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Scars lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Scars on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Scars is recruiting below its size-band peers.
2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Scars research.
AVAVA accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Scars enrolment sits around 200 participants.
Median target enrolment is 200 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Scars research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
AVAVA MIRIA General Use
AVAVA
NCT06868615
Treatment of Hypopigmented Scars With Bimatoprost
Medstar Health Research Institute
NCT06122090
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
Candela Corporation
NCT06202274
AV-23-001 AVAVA MIRIA Pilot Study
AVAVA
NCT06557434
Surgical Scar Treatment With the Pulsed Dye Laser in Combination With a CO2 Laser
Syneron Medical
NCT02898350
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Scars records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Scars trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Scars page
5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Scars trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- AVAVA sponsors the most Scars trials on record, review their full trial history before evaluating a specific study. See AVAVA's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Scars condition card totals 5 registered trials; most-linked intervention Split PDL and CO2 Laser treatment; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.